Company Filing History:
Years Active: 2013-2016
Title: Michael Pinzur: Innovator in Ankle Fusion Technology
Introduction
Michael Pinzur is a notable inventor based in Maywood, IL (US). He has made significant contributions to the field of medical devices, particularly in the area of ankle fusion technology. With a total of 2 patents to his name, Pinzur's work reflects his dedication to improving surgical outcomes for patients.
Latest Patents
One of Michael Pinzur's latest patents is an innovative ankle fusion device, which includes advanced instrumentation and methods. This device features a proximal portion that is generally aligned with a first longitudinal axis. The proximal portion consists of a proximal end and a first fastener hole, designed to receive a first fastener along a specific axis. The unique design includes an arcuate curve, allowing the proximal end to be spaced from the first longitudinal axis in a defined direction. The distal portion of the device extends to a distal end along a second longitudinal axis, which is angled in multiple directions relative to the first longitudinal axis. This design enhances the functionality and effectiveness of the ankle fusion procedure.
Career Highlights
Throughout his career, Michael Pinzur has worked with prominent companies in the medical device industry. Notably, he has been associated with Stryker European Holdings LLC and Small Bone Innovations, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Michael has collaborated with esteemed colleagues in the field, including Martinus Richter and James DeOrio. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical technology.
Conclusion
Michael Pinzur's contributions to ankle fusion technology exemplify his commitment to innovation in the medical field. His patents and collaborations reflect a dedication to improving patient care through advanced medical devices.